Facial Emotion Processing and GABAergic Modulation in Individuals at Clinical High-Risk for Psychosis
Year: 2026
Type: preprint
Study design: Clinical Trial
Abstract: Deficits in social cognition, including facial emotion recognition (FER), are present in individuals at clinical high-risk for psychosis (CHR-P). Altered GABAergic and glutamatergic signalling within corticolimbic circuitry has been proposed to underlie FER deficits in psychosis. We investigated FER performance and brain activation in CHR-P individuals, and whether pharmacological enhancement of GABAergic signalling with diazepam modulates these processes. In Study 1, 24 antipsychotic-naïve CHR-P individuals and 24 healthy controls underwent fMRI while performing the Penn Emotion Recognition Task. In Study 2, 24 antipsychotic-naïve CHR-P individuals participated in a randomised, double-blind, placebo-controlled, crossover study of 5mg diazepam versus placebo. Threat-related FER performance and neural activation were compared between groups and drug conditions. In Study 1, CHR-P individuals showed longer reaction times across emotions (n=22 vs n=23, p =0.01) and greater amygdala ( p FWE =0.01) and hippocampal ( p FWE =0.04) activation for neutral>fixation. Lower amygdala activation for threat>neutral ( p FWE =0.03) and non-threat>neutral ( p FWE =0.01), and lower hippocampal activation for non-threat>neutral ( p FWE =0.04) may reflect this elevated response to neutral faces. Follow-up analyses showed lower insula ( p FWE =0.01) and medial prefrontal cortex activation ( p FWE =0.02) for threat>fixation. In Study 2, no significant drug effect on sensitivity was observed in the full sample (n=23), although secondary reduced-sample analyses, excluding one participant identified as influential, suggested improved overall sensitivity under diazepam (n=22; p =0.0499). After adjusting for global cerebral blood flow, diazepam reduced midcingulate cortex activation during neutral>fixation (pFWE=0.04). These findings highlight altered neural processing of neutral expressions in individuals at CHR-P, and suggest that aspects of emotion processing may be sensitive to GABAergic modulation.
Source: medRxiv
Authors: Nikita C Julius, Paulina B Lukow, Amanda Kiemes, Nicholas R Livingston, Maria-Mihaela Avram, Samuel R Knight, Peter CT Hawkins, Owen O’Daly, Luke Jelen, Thomas J Reilly, Aikaterini Dima, Maria A Nettis, Cecilia Casetta, Natasha Vorontsova, James Davies, Matthew B Wall, Thomas J Spencer, Andrea de Micheli, Paolo Fusar-Poli, Anthony A Grace, Kosha Ruparel, Ruben C Gur, Fernando Zelaya, Steven CR Williams, Philip McGuire, Federico Turkheimer, Mitul A Mehta, Edward Chesney, Gemma Modinos
Institutions: King's College London, University College London, St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, Harvard University, Mass General Brigham, South London and Maudsley NHS Foundation Trust, University of Oxford, Imperial College London, Oxleas NHS Foundation Trust, University of Exeter, University of Pavia, NIHR Maudsley Biomedical Research Centre, University of Pittsburgh, Children's Hospital of Philadelphia, University of Pennsylvania
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7233815622
